Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making ...

The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide treatment decisions for patients with advanced prostate cancer. The guide, ...

The U.S. Food and Drug Administration (FDA) has approved Guardant360 CDx as a companion diagnostic to identify patients with ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...

Genetic tests for cancer on NHS to help families detect ‘Jolie’ gene - Health secretary Wes Streeting has backed the plans ...

A review of the distribution of risk estimates from three commonly used genomic assays for breast cancer found that Black women were more likely to have aggressive tumor phenotypes, which contributed ...

A nationwide Australian pilot screened more than 10,000 adults aged 18–40 years for high-risk genetic variants linked to ...

Thousands of people in England will be able to check whether they have genes linked to cancer.

"The collaboration with Tempus will substantially augment our existing precision oncology capabilities. Northwestern Medicine will now offer next-generation sequencing to patients with earlier-stage ...

FDA approves Guardant Health's blood test to help identify metastatic colorectal cancer patients eligible for targeted ...